Insights

The Insights Report – Education

3rd November 2021
You might also like
11 Dec 2024

Impact Report 2024: Highlights

Impact Report 2024: Highlights We’re pleased to share our Impact Report 2024 Highlights. Our impact report demonstrates our approach
Continue Reading »
12 Oct 2022

Volpara Receives B Corp Certification

Volpara Health Technologies (“Volpara”), which provides clinically validated software for the early detection of breast cancer, has been certified
Continue Reading »
13 Oct 2022

Botanix delivers clinically meaningful results in its BTX 1702 Phase 1b/2 clinical study

Botanix Pharmaceuticals has announced its BTX 1702 Phase 1b/2 clinical study on papulopustular rosacea has produced clinically meaningful data. 
Continue Reading »